Literature DB >> 15328166

Arzoxifene: a promising new selective estrogen receptor modulator for clinical chemoprevention of breast cancer.

Michael B Sporn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15328166     DOI： 10.1158/1078-0432.CCR-04-1377

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  4 in total

1.  Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer.

Authors:  Rui Xiong; Hitisha K Patel; Lauren M Gutgesell; Jiong Zhao; Loruhama Delgado-Rivera; Thao N D Pham; Huiping Zhao; Kathryn Carlson; Teresa Martin; John A Katzenellenbogen; Terry W Moore; Debra A Tonetti; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2015-12-30       Impact factor: 7.446

Review 2.  Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer.

Authors:  Jing Peng; Surojeet Sengupta; V Craig Jordan
Journal:  Anticancer Agents Med Chem       Date:  2009-06       Impact factor: 2.505

3.  Selective estrogen receptor modulator BC-1 activates antioxidant signaling pathway in vitro via formation of reactive metabolites.

Authors:  Bo-lan Yu; Zi-xin Mai; Xu-xiang Liu; Zhao-feng Huang
Journal:  Acta Pharmacol Sin       Date:  2013-01-21       Impact factor: 6.150

Review 4.  Selective estrogen receptor modulators: tissue specificity and clinical utility.

Authors:  Stephen Martinkovich; Darshan Shah; Sonia Lobo Planey; John A Arnott
Journal:  Clin Interv Aging       Date:  2014-08-28       Impact factor: 4.458
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.